Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Tumor Vaccines for Malignant Gliomas
/in Glioblastoma, International PublicationsTemperature induces significant changes in both glycolytic reserve and mitochondrial spare respiratory capacity in colorectal cancer cell lines
/in Colorectal Cancer, Hyperthermia, International PublicationsDynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsCurrent status of clinical trials assessing oncolytic virus therapy for urological cancers
/in Hypernephroma, International Publications, Newcastle Disease Virus, Prostate Cancer, Urothelial CarcinomaOptimizing non-invasive radiofrequency hyperthermia treatment for improving drug delivery in 4T1 mouse breast cancer model
/in Breast Cancer, Hyperthermia, International PublicationsImmune and viral therapies for malignant primary brain tumors
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease VirusA comprehensive review of immunotherapies in prostate cancer
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Prostate CancerExosomes: From Garbage Bins to Promising Therapeutic Targets
/in Exosome, International PublicationsIOZK Artikel im Austin Oncology Case Reports über Krebsimpfstoffe
/in IOZK In der Presse, IOZK VeröffentlichungenImmunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International PublicationsRecombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease VirusSafety, efficacy, and immunogenicity of autologous tumor lysate-pulsed dendritic cell vaccination therapy after resection of stage IIA (T2N0, T3N0) esophageal cancer: A phase I trial.
/in Dendritic Cells, Esophageal Carcinoma, International PublicationsDendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study
/in Dendritic Cells, International Publications, Prostate CancerShort-course preoperative radiotherapy combined with chemotherapy, delayed surgery and local hyperthermia for rectal cancer: a phase II study
/in Colorectal Cancer, Hyperthermia, International PublicationsTargeting therapy-resistant cancer stem cells by hyperthermia
/in Hyperthermia, International PublicationsA Dendritic Cell Vaccine Combined With Radiotherapy Activates the Specific Immune Response in Patients With Esophageal Cancer
/in Dendritic Cells, Esophageal Carcinoma, International PublicationsHistory and current state of immunotherapy in glioma and brain metastasis
/in Glioblastoma, International PublicationsImmunotherapy for the treatment of multiple myeloma
/in Dendritic Cells, International Publications, Multiple MyelomaChemoradiation combined with regional hyperthermia for advanced oesophageal cancer: a systematic review and meta-analysis
/in Esophageal Carcinoma, Hyperthermia, International PublicationsTargeting immune checkpoints in malignant glioma
/in Checkpoint-Inhibitors, Glioblastoma, International Publications